Iovance Biotherapeutics, Inc.
IOVA
Jodie situation report
Iovance Biotherapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 16 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 20 directly disclosed connections are confirming.
- IOVA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if IOVA's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind IOVA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
FROFrontline plcpartnerAug 7, 2025 ▾
“Through ongoing academic collaborations, as well as government and other partners, we are investigating the next frontier for TIL cell therapy in other tumor types and treatment settings.”
JEFJefferies Financial Group Inc.partnerNov 6, 2025 ▾
“On June 16, 2023, we entered into a new Open Market Sale Agreement, or the 2023 Sale Agreement, with Jefferies with respect to an “at the market” offering program.”
Depended on by
CRSPCRISPR Therapeutics AGcompetitorFeb 12, 2026 ▾
“These competitors are developing ex vivo CAR T therapies, in vivo CAR T therapies, and stem cell-derived cell therapies and include Allogene, Autolus, BlueRock Therapeutics (acquired by Bayer in 2019), Bristol Myers Squibb, Caribou Biosciences, Cellectis, Fat…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 24 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
IOVA is currently a Follower in the organic co-movement group Regional Banks & Financials. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for IOVA; it is not active in the latest market snapshot.